(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 130.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Nautilus Biotechnology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast NAUT's revenue for 2025 to be $25,229,694, with the lowest NAUT revenue forecast at $25,229,694, and the highest NAUT revenue forecast at $25,229,694. On average, 2 Wall Street analysts forecast NAUT's revenue for 2026 to be $494,123,553, with the lowest NAUT revenue forecast at $92,719,125, and the highest NAUT revenue forecast at $895,654,130.
In 2027, NAUT is forecast to generate $2,285,557,961 in revenue, with the lowest revenue forecast at $2,285,557,961 and the highest revenue forecast at $2,285,557,961.